All Stories

  1. Comment on: Key factors contributing to gender inequity in global rheumatology awards: a global survey analysis: Reply
  2. Key factors contributing to gender inequity in global rheumatology awards: a global survey analysis
  3. Translation of Rheumatoid Arthritis Disease Activity Index-5 (RADAI-5) to Punjabi Language Version and Its Correlation with Disease Activity Score 28 (DAS28) and Clinical Disease Activity Index (CDAI)
  4. Assessing the sensitivity and specificity of myositis-specific and associated autoantibodies: a sub-study from the MyoCite cohort
  5. Comment on: Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-survey: Reply
  6. COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: results from the COVAD study
  7. Impact of COVID-19 on Rheumatic Diseases in India: Determinants of Mortality and Adverse Outcome: A Retrospective, Cross-Sectional Cohort Study
  8. Autoinflammation and Autoimmunity: More to What Meets the Eye
  9. Clinical Spectrum and Outcomes of Patients with Anti-Jo1 Positive Antisynthetase Syndrome Seen at a Single Tertiary Care Hospital in North India
  10. Contact Tracing of Healthcare Workers Exposed to COVID-19 Infection in a Tertiary-Care Hospital: Containing the Contagion
  11. COVID-19 vaccination in autoimmune diseases (COVAD) study: vaccine safety and tolerance in rheumatoid arthritis
  12. COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Dise...
  13. Tacrolimus induces remission in refractory and relapsing lupus nephritis by decreasing P-glycoprotein expression and function on peripheral blood lymphocytes
  14. Polymorphism of genes involved in methotrexate pathway: Predictors of response to methotrexate therapy in Indian rheumatoid arthritis patients
  15. Deficiency of Adenosine Deaminase 2 in Adults and Children: Experience From India
  16. CD39 positive regulatory T cell frequency as a biomarker of treatment response to methotrexate in rheumatoid arthritis
  17. Association of ITGAM, TNFSF4, TNFAIP3 and STAT4 gene polymorphisms with risk of systemic lupus erythematosus in a North Indian population
  18. Successful use of azathioprine in glucocorticoid refractory immune amegakaryocytic thrombocytopenia of lupus
  19. Sternoclavicular joint arthritis as the initial presentation of sarcoidosis
  20. Chronic nonbacterial osteomyelitis from a tertiary care referral center
  21. Differences between adult and pediatric onset Henoch-Schonlein purpura from North India
  22. Rice Bodies in Tuberculous Tenosynovitis of Wrist
  23. Ochronosis: a close mimic of ankylosing spondylitis
  24. 050. ASSOCIATION OF TNFSF4 POLYMORPHISM IN SYSTEMIC LUPUS ERYTHEMATOSUS IN THE NORTH INDIAN POPULATION
  25. A rare presentation of hypopituitarism in hepatic overlap syndrome of autoimmune hepatitis and autoimmune cholangitis
  26. Exacerbation of latent lupus: is the culprit acid-fast bacilli or antitubercular therapy?
  27. Spectroscopic correlation and role of Azathioprine in long-term remission in patients of Hashimoto encephalopathy
  28. Viral myositis as a close mimicker of polymyositis
  29. Evaluation of disease activity in Rheumatoid arthritis by RAPID3
  30. A Rare Presentation of Acute Alcohol Intoxication, Subarachnoid Haemorrhage and Cortical Venous Sinus Thrombosis
  31. Role of magnesium sulfate in neuroprotection in acute ischemic stroke
  32. Assessment of hand functions in rheumatoid arthritis using SF-SACRAH (short form score for the assessment and quantification of chronic rheumatoid affections of the hands) and its correlation to disease activity
  33. P18 Evaluation of disease activity in rheumatoid arthritis using RAPID3 and its correlation with DAS-28 and CDAI
  34. P36 Assessment of evidence of accelerated atherosclerosis in patients of systemic lupus erythematosus with disease duration <5 years
  35. Use of Clinical Disease Activity Index Score for Assessment of Disease Activity in Rheumatoid Arthritis Patients: An Indian Experience
  36. P22 Comparison of clinical disease activity index (Indian version) with disease activity score-28 (DAS-28) in assessment of disease activity in rheumatoid arthritis (RA) patients
  37. P4 Epidemiology, demography and clinical profile of SLE in Haryana
  38. An unusual presentation of brucellosis